RU2003103780A - COMPOUNDS OF Phenylpyridazine AND THEIR MEDICINES CONTAINING THEM - Google Patents
COMPOUNDS OF Phenylpyridazine AND THEIR MEDICINES CONTAINING THEMInfo
- Publication number
- RU2003103780A RU2003103780A RU2003103780/04A RU2003103780A RU2003103780A RU 2003103780 A RU2003103780 A RU 2003103780A RU 2003103780/04 A RU2003103780/04 A RU 2003103780/04A RU 2003103780 A RU2003103780 A RU 2003103780A RU 2003103780 A RU2003103780 A RU 2003103780A
- Authority
- RU
- Russia
- Prior art keywords
- substituted
- unsubstituted
- methoxyphenyl
- pyridazine
- group
- Prior art date
Links
- 239000003814 drug Substances 0.000 title claims 6
- 150000001875 compounds Chemical class 0.000 title claims 2
- XWSSUYOEOWLFEI-UHFFFAOYSA-N 3-phenylpyridazine Chemical compound C1=CC=CC=C1C1=CC=CN=N1 XWSSUYOEOWLFEI-UHFFFAOYSA-N 0.000 title 1
- -1 phenylpyridazine compound Chemical class 0.000 claims 21
- 150000003839 salts Chemical class 0.000 claims 11
- 239000011780 sodium chloride Substances 0.000 claims 11
- 229910052739 hydrogen Inorganic materials 0.000 claims 9
- 239000001257 hydrogen Substances 0.000 claims 9
- 229910052736 halogen Inorganic materials 0.000 claims 7
- 150000002367 halogens Chemical class 0.000 claims 7
- 125000003545 alkoxy group Chemical group 0.000 claims 6
- 125000000217 alkyl group Chemical group 0.000 claims 5
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims 5
- 125000004414 alkyl thio group Chemical group 0.000 claims 5
- 201000010099 disease Diseases 0.000 claims 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 5
- 150000002431 hydrogen Chemical class 0.000 claims 4
- 238000004519 manufacturing process Methods 0.000 claims 4
- 125000001424 substituent group Chemical group 0.000 claims 4
- 125000003342 alkenyl group Chemical group 0.000 claims 3
- 229940079593 drugs Drugs 0.000 claims 3
- 239000004615 ingredient Substances 0.000 claims 3
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims 3
- 125000003356 phenylsulfanyl group Chemical group [*]SC1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims 3
- 230000002265 prevention Effects 0.000 claims 3
- 125000004076 pyridyl group Chemical group 0.000 claims 3
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 claims 2
- 102000003777 Interleukin-1 beta Human genes 0.000 claims 2
- 108090000193 Interleukin-1 beta Proteins 0.000 claims 2
- 125000004644 alkyl sulfinyl group Chemical group 0.000 claims 2
- 125000005278 alkyl sulfonyloxy group Chemical group 0.000 claims 2
- 125000005530 alkylenedioxy group Chemical group 0.000 claims 2
- 125000003277 amino group Chemical group 0.000 claims 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 2
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 claims 2
- 125000006518 morpholino carbonyl group Chemical group [H]C1([H])OC([H])([H])C([H])([H])N(C(*)=O)C1([H])[H] 0.000 claims 2
- 125000005554 pyridyloxy group Chemical group 0.000 claims 2
- 230000000638 stimulation Effects 0.000 claims 2
- UMIZQPPQIJQBBU-UHFFFAOYSA-N 2-[5,6-bis(4-methoxyphenyl)pyridazin-3-yl]oxybenzonitrile Chemical compound C1=CC(OC)=CC=C1C1=CC(OC=2C(=CC=CC=2)C#N)=NN=C1C1=CC=C(OC)C=C1 UMIZQPPQIJQBBU-UHFFFAOYSA-N 0.000 claims 1
- JLEPZUZKHQGZAQ-UHFFFAOYSA-N 3,4-bis(4-methoxyphenyl)-6-(2,3,4,5,6-pentafluorophenoxy)pyridazine Chemical compound C1=CC(OC)=CC=C1C1=CC(OC=2C(=C(F)C(F)=C(F)C=2F)F)=NN=C1C1=CC=C(OC)C=C1 JLEPZUZKHQGZAQ-UHFFFAOYSA-N 0.000 claims 1
- VTVQNZDIYAEJIS-UHFFFAOYSA-N 3,4-bis(4-methoxyphenyl)-6-(2,3,5,6-tetrafluorophenoxy)pyridazine Chemical compound C1=CC(OC)=CC=C1C1=CC(OC=2C(=C(F)C=C(F)C=2F)F)=NN=C1C1=CC=C(OC)C=C1 VTVQNZDIYAEJIS-UHFFFAOYSA-N 0.000 claims 1
- MYRUVVDBOMCWGW-UHFFFAOYSA-N 3,4-bis(4-methoxyphenyl)-6-(3,4,5-trichlorophenyl)sulfanylpyridazine Chemical compound C1=CC(OC)=CC=C1C1=CC(SC=2C=C(Cl)C(Cl)=C(Cl)C=2)=NN=C1C1=CC=C(OC)C=C1 MYRUVVDBOMCWGW-UHFFFAOYSA-N 0.000 claims 1
- CPSCTYKMUFSDPS-UHFFFAOYSA-N 3,4-bis(4-methoxyphenyl)-6-(4-nitrophenoxy)pyridazine Chemical compound C1=CC(OC)=CC=C1C1=CC(OC=2C=CC(=CC=2)[N+]([O-])=O)=NN=C1C1=CC=C(OC)C=C1 CPSCTYKMUFSDPS-UHFFFAOYSA-N 0.000 claims 1
- FRUXLWZCQLIZQW-UHFFFAOYSA-N 3,4-bis(4-methoxyphenyl)-6-phenoxypyridazine Chemical compound C1=CC(OC)=CC=C1C1=CC(OC=2C=CC=CC=2)=NN=C1C1=CC=C(OC)C=C1 FRUXLWZCQLIZQW-UHFFFAOYSA-N 0.000 claims 1
- WOLBFZNGJJCORG-UHFFFAOYSA-N 3-(4-methoxyphenyl)-6-(2,3,4,5,6-pentafluorophenoxy)-4-phenylpyridazine Chemical compound C1=CC(OC)=CC=C1C(C(=C1)C=2C=CC=CC=2)=NN=C1OC1=C(F)C(F)=C(F)C(F)=C1F WOLBFZNGJJCORG-UHFFFAOYSA-N 0.000 claims 1
- SINCNTXLXVEREY-UHFFFAOYSA-N 3-(4-methylsulfanylphenyl)-6-phenylsulfanyl-4-(4-phenylsulfanylphenyl)pyridazine Chemical compound C1=CC(SC)=CC=C1C(C(=C1)C=2C=CC(SC=3C=CC=CC=3)=CC=2)=NN=C1SC1=CC=CC=C1 SINCNTXLXVEREY-UHFFFAOYSA-N 0.000 claims 1
- LMVYLDPAAZWNLU-UHFFFAOYSA-N 3-[5,6-bis(4-methoxyphenyl)pyridazin-3-yl]oxybenzonitrile Chemical compound C1=CC(OC)=CC=C1C1=CC(OC=2C=C(C=CC=2)C#N)=NN=C1C1=CC=C(OC)C=C1 LMVYLDPAAZWNLU-UHFFFAOYSA-N 0.000 claims 1
- YMOFKBQTXYSYOS-UHFFFAOYSA-N 4-(4-chlorophenyl)-6-(2,4-difluorophenoxy)-3-(4-methylsulfanylphenyl)pyridazine Chemical compound C1=CC(SC)=CC=C1C(C(=C1)C=2C=CC(Cl)=CC=2)=NN=C1OC1=CC=C(F)C=C1F YMOFKBQTXYSYOS-UHFFFAOYSA-N 0.000 claims 1
- KYZZXEOLAKRXPR-UHFFFAOYSA-N 5,6-bis(4-methoxyphenyl)pyridazine-3-carbonitrile Chemical compound C1=CC(OC)=CC=C1C1=CC(C#N)=NN=C1C1=CC=C(OC)C=C1 KYZZXEOLAKRXPR-UHFFFAOYSA-N 0.000 claims 1
- KRRZBNPICSYCJJ-UHFFFAOYSA-N 6-(2,3-difluorophenoxy)-3,4-bis(4-methoxyphenyl)pyridazine Chemical compound C1=CC(OC)=CC=C1C1=CC(OC=2C(=C(F)C=CC=2)F)=NN=C1C1=CC=C(OC)C=C1 KRRZBNPICSYCJJ-UHFFFAOYSA-N 0.000 claims 1
- GYFRRMMAYVZXOR-UHFFFAOYSA-N 6-(2,3-difluorophenoxy)-3-(4-methoxyphenyl)-4-phenylpyridazine Chemical compound C1=CC(OC)=CC=C1C(C(=C1)C=2C=CC=CC=2)=NN=C1OC1=CC=CC(F)=C1F GYFRRMMAYVZXOR-UHFFFAOYSA-N 0.000 claims 1
- QJWXPWBCLUUKHF-UHFFFAOYSA-N 6-(2,4-difluorophenoxy)-3-(4-methoxyphenyl)-4-phenylpyridazine Chemical compound C1=CC(OC)=CC=C1C(C(=C1)C=2C=CC=CC=2)=NN=C1OC1=CC=C(F)C=C1F QJWXPWBCLUUKHF-UHFFFAOYSA-N 0.000 claims 1
- RDBNGGYFDSHJHD-UHFFFAOYSA-N 6-(2,4-difluorophenoxy)-3-(4-methoxyphenyl)-4-pyridin-4-ylpyridazine Chemical compound C1=CC(OC)=CC=C1C(C(=C1)C=2C=CN=CC=2)=NN=C1OC1=CC=C(F)C=C1F RDBNGGYFDSHJHD-UHFFFAOYSA-N 0.000 claims 1
- FUTSWKWNRJOAAL-UHFFFAOYSA-N 6-(2,5-difluorophenoxy)-3,4-bis(4-methoxyphenyl)pyridazine Chemical compound C1=CC(OC)=CC=C1C1=CC(OC=2C(=CC=C(F)C=2)F)=NN=C1C1=CC=C(OC)C=C1 FUTSWKWNRJOAAL-UHFFFAOYSA-N 0.000 claims 1
- LKORWDQWRQFXMA-UHFFFAOYSA-N 6-(2,6-difluorophenoxy)-3,4-bis(4-methoxyphenyl)pyridazine Chemical compound C1=CC(OC)=CC=C1C1=CC(OC=2C(=CC=CC=2F)F)=NN=C1C1=CC=C(OC)C=C1 LKORWDQWRQFXMA-UHFFFAOYSA-N 0.000 claims 1
- XOVNKMFNEVDUAR-UHFFFAOYSA-N 6-(3,4-difluorophenoxy)-3,4-bis(4-methoxyphenyl)pyridazine Chemical compound C1=CC(OC)=CC=C1C1=CC(OC=2C=C(F)C(F)=CC=2)=NN=C1C1=CC=C(OC)C=C1 XOVNKMFNEVDUAR-UHFFFAOYSA-N 0.000 claims 1
- SEPMINNDOOHVOE-UHFFFAOYSA-N 6-(4-methoxyphenoxy)-3,4-bis(4-methoxyphenyl)pyridazine Chemical compound C1=CC(OC)=CC=C1OC1=CC(C=2C=CC(OC)=CC=2)=C(C=2C=CC(OC)=CC=2)N=N1 SEPMINNDOOHVOE-UHFFFAOYSA-N 0.000 claims 1
- OBZRAXPMQFJNAL-UHFFFAOYSA-N 6-(4-methoxyphenyl)-5-phenylpyridazine-3-carbonitrile Chemical compound C1=CC(OC)=CC=C1C1=NN=C(C#N)C=C1C1=CC=CC=C1 OBZRAXPMQFJNAL-UHFFFAOYSA-N 0.000 claims 1
- 206010003246 Arthritis Diseases 0.000 claims 1
- 206010009887 Colitis Diseases 0.000 claims 1
- 210000000987 Immune System Anatomy 0.000 claims 1
- 208000001132 Osteoporosis Diseases 0.000 claims 1
- 206010072736 Rheumatic disease Diseases 0.000 claims 1
- 206010040047 Sepsis Diseases 0.000 claims 1
- 125000003118 aryl group Chemical group 0.000 claims 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims 1
- 239000000969 carrier Substances 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 201000008739 coronary artery disease Diseases 0.000 claims 1
- 125000005843 halogen group Chemical group 0.000 claims 1
- 125000000623 heterocyclic group Chemical group 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 230000002757 inflammatory Effects 0.000 claims 1
- 200000000018 inflammatory disease Diseases 0.000 claims 1
- 239000003112 inhibitor Substances 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- 125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 claims 1
Claims (13)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/612,953 US6664256B1 (en) | 2000-07-10 | 2000-07-10 | Phenylpyridazine compounds and medicines containing the same |
US09/612,953 | 2000-07-10 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2003103780A true RU2003103780A (en) | 2004-08-20 |
RU2269519C2 RU2269519C2 (en) | 2006-02-10 |
Family
ID=24455274
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2003103780/04A RU2269519C2 (en) | 2000-07-10 | 2001-07-06 | Phenylpyridazine compounds and medicinal agents comprising thereof |
Country Status (15)
Country | Link |
---|---|
US (1) | US6664256B1 (en) |
EP (1) | EP1300399B1 (en) |
JP (1) | JP4915715B2 (en) |
KR (1) | KR100777623B1 (en) |
CN (1) | CN1272326C (en) |
AT (1) | ATE370735T1 (en) |
AU (2) | AU6947401A (en) |
CA (1) | CA2413042A1 (en) |
DE (1) | DE60130119T2 (en) |
HU (1) | HUP0301230A3 (en) |
NO (1) | NO324219B1 (en) |
NZ (1) | NZ523242A (en) |
RU (1) | RU2269519C2 (en) |
TW (1) | TW593285B (en) |
WO (1) | WO2002004427A1 (en) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1043317B1 (en) * | 1997-11-19 | 2009-04-15 | Kowa Co., Ltd. | Pyridazine derivatives and medicaments containing them as active ingredient |
WO2003027077A1 (en) * | 2001-09-26 | 2003-04-03 | Kowa Co., Ltd. | Water-soluble phenylpyridazine derivatives and drugs containing the same |
WO2003099284A1 (en) | 2002-05-22 | 2003-12-04 | Amgen Inc. | Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain |
AU2003264047B2 (en) | 2002-08-08 | 2008-06-26 | Amgen Inc. | Vanilloid receptor ligands and their use in treatments |
EP1688408A3 (en) * | 2002-08-08 | 2007-08-22 | Amgen, Inc | Vanilloid receptor ligands and their use in treatments |
RU2328495C2 (en) * | 2003-03-07 | 2008-07-10 | Кова Ко., Лтд. | Benzofuran derivatives |
RU2005132167A (en) * | 2003-03-18 | 2006-05-10 | Кова Ко., Лтд. (Jp) | WATER-SOLUBLE DERIVATIVES OF PHENYL-PYRIDAZINE AND MEDICINES CONTAINING THEM |
WO2005012259A1 (en) * | 2003-07-30 | 2005-02-10 | Kowa Co., Ltd. | Method of inhibiting production of osteopontin |
PL3428257T3 (en) | 2003-09-29 | 2023-11-20 | Deb Ip Limited | High alcohol content gel-like and foaming compositions |
BRPI0513359A (en) | 2004-07-15 | 2008-05-06 | Amr Technology Inc | aryl and heteroaryl substituted tetrahydroisoquinolines and use of these to block the reuptake of norepinephrine, dopamine, and serotonin |
DE102004062775A1 (en) | 2004-12-21 | 2006-06-29 | Stockhausen Gmbh | Alcoholic pump foam |
BRPI0608347A2 (en) | 2005-03-07 | 2009-12-08 | Deb Worldwide Healthcare Inc | foaming alcohol composition, foaming concentrate, foaming disinfectant alcohol composition, methods for forming, producing and dispensing a foam, unpressurized dispenser, and methods for using an alcoholic foam composition for personal disinfection and for producing and applying to an individual's skin an alcoholic composition of skin disinfectant foam |
TW200716594A (en) * | 2005-04-18 | 2007-05-01 | Neurogen Corp | Substituted heteroaryl CB1 antagonists |
WO2007123939A2 (en) * | 2006-04-19 | 2007-11-01 | Laboratoires Serono S.A. | Novel arylamino n-heteraryls as mek inhibitors |
US8580860B2 (en) * | 2007-02-23 | 2013-11-12 | Gojo Industries, Inc. | Foamable alcoholic composition |
AR071997A1 (en) * | 2008-06-04 | 2010-07-28 | Bristol Myers Squibb Co | CRYSTAL FORM OF 6 - ((4S) -2-METHYL-4- (2-NAFTIL) -1,2,3,4-TETRAHYDROISOQUINOLIN-7-IL) PIRIDAZIN-3-AMINA |
US9156812B2 (en) | 2008-06-04 | 2015-10-13 | Bristol-Myers Squibb Company | Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine |
KR20120034644A (en) | 2009-05-12 | 2012-04-12 | 알바니 몰레큘라 리써치, 인크. | Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof |
CA2788355C (en) | 2010-02-18 | 2018-03-06 | Devi Reddy Gohimukkula | Phenyl-heteroaryl derivatives and methods of use thereof |
WO2012031383A1 (en) * | 2010-09-06 | 2012-03-15 | 中国科学院广州生物医药与健康研究院 | Amide compounds |
GB201106829D0 (en) | 2011-04-21 | 2011-06-01 | Proximagen Ltd | Heterocyclic compounds |
WO2012111024A1 (en) | 2011-02-18 | 2012-08-23 | Suven Nishtaa Pharma Pvt Ltd | Pharmaceutical compositions of dexlansoprazole |
WO2021193897A1 (en) * | 2020-03-27 | 2021-09-30 | アステラス製薬株式会社 | Substituted pyridazine compound |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3840597A (en) | 1971-02-24 | 1974-10-08 | Riker Laboratories Inc | Substituted 2-phenoxy alkane-sulfonanilides |
US4092311A (en) * | 1976-06-03 | 1978-05-30 | American Cyanamid Company | Hypotensive alkyl-3-[6-(aryl)-3-pyridazinyl]-carbazates |
JPH0753725B2 (en) | 1987-10-08 | 1995-06-07 | 富山化学工業株式会社 | 4H-1-benzopyran-4-one derivative and its salt, their production method and anti-inflammatory agent containing them |
FI91062C (en) | 1988-12-28 | 1994-05-10 | Eisai Co Ltd | Process for the preparation of naphthalene derivatives useful as a medicament |
JPH06501926A (en) * | 1990-08-06 | 1994-03-03 | 藤沢薬品工業株式会社 | heterocyclic compound |
MX9300141A (en) | 1992-01-13 | 1994-07-29 | Smithkline Beecham Corp | NOVEL IMIDAZOLE COMPOUNDS, PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT. |
ES2114654T3 (en) | 1993-06-08 | 1998-06-01 | Vertex Pharma | PIRIDAZINES AS INHIBITORS OF THE INTERLEUKIN-1BETA CONVERSION ENZYME. |
US5593994A (en) | 1994-09-29 | 1997-01-14 | The Dupont Merck Pharmaceutical Company | Prostaglandin synthase inhibitors |
CA2228050A1 (en) | 1995-08-10 | 1997-02-20 | Harold G. Selnick | 2,5-substituted aryl pyrroles, compositions containing such compounds and methods of use |
DE69825154T2 (en) | 1997-03-14 | 2005-07-21 | Merck Frosst Canada & Co, Kirkland | PYRIDAZINONE AS INHIBITORS OF CYCLOOXYGENASE-2 |
DE69833774T2 (en) | 1997-08-22 | 2007-04-26 | Abbott Laboratories, Abbott Park | PROSTAGLANDIN ENDOPEROXYDE H SYNTHASE BIOSYNTHESIS INHIBITORS |
EP1007515A1 (en) | 1997-08-22 | 2000-06-14 | Abbott Laboratories | Arylpyridazinones as prostaglandin endoperoxide h synthase biosynthesis inhibitors |
JP3999861B2 (en) * | 1997-11-19 | 2007-10-31 | 興和株式会社 | Novel pyridazine derivatives and pharmaceuticals containing the same as active ingredients |
EP1043317B1 (en) | 1997-11-19 | 2009-04-15 | Kowa Co., Ltd. | Pyridazine derivatives and medicaments containing them as active ingredient |
PT1042293E (en) * | 1997-12-19 | 2008-04-18 | Amgen Inc | Substituted pyridine and pyridazine compounds and their pharmaceutical use |
TWI241295B (en) | 1998-03-02 | 2005-10-11 | Kowa Co | Pyridazine derivative and medicine containing the same as effect component |
DE69926903T2 (en) | 1998-10-27 | 2006-07-13 | Abbott Laboratories, Abbott Park | PROSTAGLANDIN ENDOPEROXYDE H SYNTHASE BIOSYNTHESIS INHIBITORS |
US6350744B1 (en) * | 1998-11-20 | 2002-02-26 | Merck & Co., Inc. | Compounds having cytokine inhibitory activity |
US6602872B1 (en) | 1999-12-13 | 2003-08-05 | Merck & Co., Inc. | Substituted pyridazines having cytokine inhibitory activity |
-
2000
- 2000-07-10 US US09/612,953 patent/US6664256B1/en not_active Expired - Fee Related
-
2001
- 2001-07-06 NZ NZ523242A patent/NZ523242A/en unknown
- 2001-07-06 HU HU0301230A patent/HUP0301230A3/en unknown
- 2001-07-06 CN CNB018120962A patent/CN1272326C/en not_active Expired - Fee Related
- 2001-07-06 AU AU6947401A patent/AU6947401A/en active Pending
- 2001-07-06 KR KR1020027016860A patent/KR100777623B1/en not_active IP Right Cessation
- 2001-07-06 CA CA002413042A patent/CA2413042A1/en not_active Abandoned
- 2001-07-06 DE DE60130119T patent/DE60130119T2/en not_active Expired - Lifetime
- 2001-07-06 WO PCT/JP2001/005904 patent/WO2002004427A1/en active IP Right Grant
- 2001-07-06 EP EP01947902A patent/EP1300399B1/en not_active Expired - Lifetime
- 2001-07-06 AU AU2001269474A patent/AU2001269474B2/en not_active Ceased
- 2001-07-06 AT AT01947902T patent/ATE370735T1/en not_active IP Right Cessation
- 2001-07-06 RU RU2003103780/04A patent/RU2269519C2/en not_active IP Right Cessation
- 2001-07-06 JP JP2002509294A patent/JP4915715B2/en not_active Expired - Fee Related
- 2001-07-10 TW TW090116864A patent/TW593285B/en not_active IP Right Cessation
-
2003
- 2003-01-09 NO NO20030097A patent/NO324219B1/en not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2003103780A (en) | COMPOUNDS OF Phenylpyridazine AND THEIR MEDICINES CONTAINING THEM | |
JP2019517487A5 (en) | ||
RU2423354C2 (en) | Compounds and compositions - hedgehog signalling pathway modulators | |
CA2412968A1 (en) | Substituted pyridines as selective cyclooxygenase-2 inhibitors | |
EP3277276B1 (en) | Methods of administering glutaminase inhibitors | |
JP2005536475A5 (en) | ||
RU2006105716A (en) | Pyridazine derivatives and their use as therapeutic agents | |
JP2018505876A5 (en) | ||
MY148375A (en) | Delta and epsilon crystal forms of imatinib mesylate | |
RU2008145225A (en) | INDAZOLE COMPOUNDS AND CD7 INHIBITION METHODS | |
JP2012507566A5 (en) | ||
JP2005501120A5 (en) | ||
RU99126510A (en) | 3 (5) -HETEROARYL SUBSTITUTED PYRAZOLES AS KINASE P38 INHIBITORS | |
CA2413313A1 (en) | Antitumor effect potentiators | |
RU2003114752A (en) | TREATMENT OF GASTROINTESTINAL STOMAL TUMORS | |
JP2013532727A5 (en) | ||
JP2010535824A (en) | Azabiphenylaminobenzoic acid derivatives as DHODH inhibitors | |
RU2013132930A (en) | Pyrazole derivative | |
RU2000115577A (en) | NEW PYRIDASINE DERIVATIVES AND MEDICINES CONTAINING THEM AS EFFECTIVE INGREDIENTS | |
RU99128053A (en) | NEW CYCLIC COMPOUNDS OF DIAMINE AND THEIR MEDICINES CONTAINING THEM | |
RU2017121044A (en) | AMIDOTHYADIAZAZOLE DERIVATIVES AS NADPH-OXIDASE INHIBITORS | |
CA2730471A1 (en) | Piperazine derivatives used as cav2.2 calcium channel modulators | |
RU2012147511A (en) | USE OF C-SRC INHIBITORS IN COMBINATION WITH PYRIMIDILAMINOBENZAMIDE FOR TREATMENT OF LEUKOSIS | |
JP2018507257A5 (en) | ||
RU2008127264A (en) | Pyrimidylamino-benzamide derivatives for the treatment of neuro-fibromatosis |